Nalidixic Selective Supplement - ARCSA Registration 7d67d1f8a2d31971f4b650c0287f290b
Access comprehensive regulatory information for Nalidixic Selective Supplement in the Ecuador medical device market through Pure Global AI's free database. This I medical device is registered under ARCSA ID 7d67d1f8a2d31971f4b650c0287f290b and manufactured by MICROXPRESS – A DIVISION OF TULIP DIAGNOSTICS (P) LTD.. The device was registered on June 02, 2023.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.
Free Database
Powered by Pure Global AI
ARCSA Official Data
I
7d67d1f8a2d31971f4b650c0287f290b
Nalidixic Selective Supplement
ARCSA ID: 7d67d1f8a2d31971f4b650c0287f290b
Device Classification
Risk Class
I
Product Type
In Vitro Diagnostic
Brand Name
MICROXPRESS; Accumix
Commercial Name
19-483 IVD Reagents/Kits, Microbiology, Bacteria, Culture Media
Registration Information
Analysis ID
7d67d1f8a2d31971f4b650c0287f290b
Registration Date
June 02, 2023
Expiration Date
June 02, 2028
Product Use
CULTURE MEDIA AND SUPPLEMENTS FOR CLINICAL LABORATORY
Manufacturer
Country
INDIA
Address
PLOT NO. S-124, S-125, S-126, UTILITY PLOT NO. VIII, PHASE III-B, VERNA INDUSTRIAL ESTATE, VERNA, GOA - 403 722, INDIA.
Product Owner
Name
MICROXPRESS – A DIVISION OF TULIP DIAGNOSTICS (P) LTD.
Country
INDIA
Authorized Representative